Citadel Advisors LLC 13D and 13G filings for Ikena Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | IKENA ONCOLOGY INC IKNA | Citadel Advisors LLC | 14,848 0.400% | -164,746 (-91.73%) | Filing |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | IKENA ONCOLOGY INC IKNA | Citadel Advisors LLC | 179,594 5.900% | 2,243 (+1.26%) | Filing |
| 2022-02-14 06:12 am Purchase | 2021-12-31 | 13G | IKENA ONCOLOGY INC IKNA | Citadel Advisors LLC | 177,351 5.900% | 6,105 (+3.57%) | Filing |